Poly-ADP Ribose Polymerase Activates Nuclear Proteasome to Degrade Oxidatively Damaged Histones
The 20S proteasome has been shown to be largely responsible for the degradation of oxidatively modified proteins in the cytoplasm. Nuclear proteins are also subject to oxidation, and the nucleus of mammalian cells contains proteasome. In human beings, tumor cells frequently are subjected to oxidatio...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 96; no. 11; pp. 6223 - 6228 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences of the United States of America
25.05.1999
National Acad Sciences National Academy of Sciences The National Academy of Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The 20S proteasome has been shown to be largely responsible for the degradation of oxidatively modified proteins in the cytoplasm. Nuclear proteins are also subject to oxidation, and the nucleus of mammalian cells contains proteasome. In human beings, tumor cells frequently are subjected to oxidation as a consequence of antitumor chemotherapy, and K562 human myelogenous leukemia cells have a higher nuclear proteasome activity than do nonmalignant cells. Adaptation to oxidative stress appears to be one element in the development of long-term resistance to many chemotherapeutic drugs and the mechanisms of inducible tumor resistance to oxidation are of obvious importance. After hydrogen peroxide treatment of K562 cells, degradation of the model proteasome peptide substrate suc-LLVY-MCA and degradation of oxidized histones in nuclei increases significantly within minutes. Both increased proteolytic susceptibility of the histone substrates (caused by modification by oxidation) and activation of the proteasome enzyme complex occur independently during oxidative stress. This rapid upregulation of 20S proteasome activity is accompanied by, and depends on, poly-ADP ribosylation of the proteasome, as shown by inhibitor experiments, 14C-ADP ribose incorporation assays, immunoblotting, in vitro reconstitution experiments, and immunoprecipitation of (activated) proteasome with anti-poly-ADP ribose polymerase antibodies. The poly-ADP ribosylation-mediated activated nuclear 20S proteasome is able to remove oxidatively damaged histones more efficiently and therefore is proposed as an oxidant-stimulatable defense or repair system of the nucleus in K562 leukemia cells. |
---|---|
AbstractList | The 20S proteasome has been shown to be largely responsible for the degradation of oxidatively modified proteins in the cytoplasm. Nuclear proteins are also subject to oxidation, and the nucleus of mammalian cells contains proteasome. In human beings, tumor cells frequently are subjected to oxidation as a consequence of antitumor chemotherapy, and K562 human myelogenous leukemia cells have a higher nuclear proteasome activity than do nonmalignant cells. Adaptation to oxidative stress appears to be one element in the development of long-term resistance to many chemotherapeutic drugs and the mechanisms of inducible tumor resistance to oxidation are of obvious importance. After hydrogen peroxide treatment of K562 cells, degradation of the model proteasome peptide substrate suc-LLVY-MCA and degradation of oxidized histones in nuclei increases significantly within minutes. Both increased proteolytic susceptibility of the histone substrates (caused by modification by oxidation) and activation of the proteasome enzyme complex occur independently during oxidative stress. This rapid up-regulation of 20S proteasome activity is accompanied by, and depends on, poly-ADP ribosylation of the proteasome, as shown by inhibitor experiments,
14
C-ADP ribose incorporation assays, immunoblotting,
in vitro
reconstitution experiments, and immunoprecipitation of (activated) proteasome with anti-poly-ADP ribose polymerase antibodies. The poly-ADP ribosylation-mediated activated nuclear 20S proteasome is able to remove oxidatively damaged histones more efficiently and therefore is proposed as an oxidant-stimulatable defense or repair system of the nucleus in K562 leukemia cells. The 20S proteasome has been shown to be largely responsible for the degradation of oxidatively modified proteins in the cytoplasm. Nuclear proteins are also subject to oxidation, and the nucleus of mammalian cells contains proteasome. In human beings, tumor cells frequently are subjected to oxidation as a consequence of antitumor chemotherapy, and K562 human myelogenous leukemia cells have a higher nuclear proteasome activity than do nonmalignant cells. Adaptation to oxidative stress appears to be one element in the development of long-term resistance to many chemotherapeutic drugs and the mechanisms of inducible tumor resistance to oxidation are of obvious importance. After hydrogen peroxide treatment of K562 cells, degradation of the model proteasome peptide substrate suc-LLVY-MCA and degradation of oxidized histones in nuclei increases significantly within minutes. Both increased proteolytic susceptibility of the histone substrates (caused by modification by oxidation) and activation of the proteasome enzyme complex occur independently during oxidative stress. This rapid up-regulation of 20S proteasome activity is accompanied by, and depends on, poly-ADP ribosylation of the proteasome, as shown by inhibitor experiments, 14 C-ADP ribose incorporation assays, immunoblotting, in vitro reconstitution experiments, and immunoprecipitation of (activated) proteasome with anti-poly-ADP ribose polymerase antibodies. The poly-ADP ribosylation-mediated activated nuclear 20S proteasome is able to remove oxidatively damaged histones more efficiently and therefore is proposed as an oxidant-stimulatable defense or repair system of the nucleus in K562 leukemia cells. The 20S proteasome has been shown to be largely responsible for the degradation of oxidatively modified proteins in the cytoplasm. Nuclear proteins are also subject to oxidation, and the nucleus of mammalian cells contains proteasome. The 20S proteasome has been shown to be largely responsible for the degradation of oxidatively modified proteins in the cytoplasm. Nuclear proteins are also subject to oxidation, and the nucleus of mammalian cells contains proteasome. In human beings, tumor cells frequently are subjected to oxidation as a consequence of antitumor chemotherapy, and K562 human myelogenous leukemia cells have a higher nuclear proteasome activity than do nonmalignant cells. Adaptation to oxidative stress appears to be one element in the development of long-term resistance to many chemotherapeutic drugs and the mechanisms of inducible tumor resistance to oxidation are of obvious importance. After hydrogen peroxide treatment of K562 cells, degradation of the model proteasome peptide substrate suc-LLVY-MCA and degradation of oxidized histones in nuclei increases significantly within minutes. Both increased proteolytic susceptibility of the histone substrates (caused by modification by oxidation) and activation of the proteasome enzyme complex occur independently during oxidative stress. This rapid up-regulation of 20S proteasome activity is accompanied by, and depends on, poly-ADP ribosylation of the proteasome, as shown by inhibitor experiments, 14C-ADP ribose incorporation assays, immunoblotting, in vitro reconstitution experiments, and immunoprecipitation of (activated) proteasome with anti-poly-ADP ribose polymerase antibodies. The poly-ADP ribosylation-mediated activated nuclear 20S proteasome is able to remove oxidatively damaged histones more efficiently and therefore is proposed as an oxidant-stimulatable defense or repair system of the nucleus in K562 leukemia cells. The 20S proteasome has been shown to be largely responsible for the degradation of oxidatively modified proteins in the cytoplasm. Nuclear proteins are also subject to oxidation, and the nucleus of mammalian cells contains proteasome. In human beings, tumor cells frequently are subjected to oxidation as a consequence of antitumor chemotherapy, and K562 human myelogenous leukemia cells have a higher nuclear proteasome activity than do nonmalignant cells. Adaptation to oxidative stress appears to be one element in the development of long-term resistance to many chemotherapeutic drugs and the mechanisms of inducible tumor resistance to oxidation are of obvious importance. After hydrogen peroxide treatment of K562 cells, degradation of the model proteasome peptide substrate suc-LLVY-MCA and degradation of oxidized histones in nuclei increases significantly within minutes. Both increased proteolytic susceptibility of the histone substrates (caused by modification by oxidation) and activation of the proteasome enzyme complex occur independently during oxidative stress. This rapid upregulation of 20S proteasome activity is accompanied by, and depends on, poly-ADP ribosylation of the proteasome, as shown by inhibitor experiments, 14C-ADP ribose incorporation assays, immunoblotting, in vitro reconstitution experiments, and immunoprecipitation of (activated) proteasome with anti-poly-ADP ribose polymerase antibodies. The poly-ADP ribosylation-mediated activated nuclear 20S proteasome is able to remove oxidatively damaged histones more efficiently and therefore is proposed as an oxidant-stimulatable defense or repair system of the nucleus in K562 leukemia cells. The 20S proteasome has been shown to be largely responsible for the degradation of oxidatively modified proteins in the cytoplasm. Nuclear proteins are also subject to oxidation, and the nucleus of mammalian cells contains proteasome. In human beings, tumor cells frequently are subjected to oxidation as a consequence of antitumor chemotherapy, and K562 human myelogenous leukemia cells have a higher nuclear proteasome activity than do nonmalignant cells. Adaptation to oxidative stress appears to be one element in the development of long-term resistance to many chemotherapeutic drugs and the mechanisms of inducible tumor resistance to oxidation are of obvious importance. After hydrogen peroxide treatment of K562 cells, degradation of the model proteasome peptide substrate suc-LLVY-MCA and degradation of oxidized histones in nuclei increases significantly within minutes. Both increased proteolytic susceptibility of the histone substrates (caused by modification by oxidation) and activation of the proteasome enzyme complex occur independently during oxidative stress. This rapid up-regulation of 20S proteasome activity is accompanied by, and depends on, poly-ADP ribosylation of the proteasome, as shown by inhibitor experiments, 14C-ADP ribose incorporation assays, immunoblotting, in vitro reconstitution experiments, and immunoprecipitation of (activated) proteasome with anti-poly-ADP ribose polymerase antibodies. The poly-ADP ribosylation-mediated activated nuclear 20S proteasome is able to remove oxidatively damaged histones more efficiently and therefore is proposed as an oxidant-stimulatable defense or repair system of the nucleus in K562 leukemia cells.The 20S proteasome has been shown to be largely responsible for the degradation of oxidatively modified proteins in the cytoplasm. Nuclear proteins are also subject to oxidation, and the nucleus of mammalian cells contains proteasome. In human beings, tumor cells frequently are subjected to oxidation as a consequence of antitumor chemotherapy, and K562 human myelogenous leukemia cells have a higher nuclear proteasome activity than do nonmalignant cells. Adaptation to oxidative stress appears to be one element in the development of long-term resistance to many chemotherapeutic drugs and the mechanisms of inducible tumor resistance to oxidation are of obvious importance. After hydrogen peroxide treatment of K562 cells, degradation of the model proteasome peptide substrate suc-LLVY-MCA and degradation of oxidized histones in nuclei increases significantly within minutes. Both increased proteolytic susceptibility of the histone substrates (caused by modification by oxidation) and activation of the proteasome enzyme complex occur independently during oxidative stress. This rapid up-regulation of 20S proteasome activity is accompanied by, and depends on, poly-ADP ribosylation of the proteasome, as shown by inhibitor experiments, 14C-ADP ribose incorporation assays, immunoblotting, in vitro reconstitution experiments, and immunoprecipitation of (activated) proteasome with anti-poly-ADP ribose polymerase antibodies. The poly-ADP ribosylation-mediated activated nuclear 20S proteasome is able to remove oxidatively damaged histones more efficiently and therefore is proposed as an oxidant-stimulatable defense or repair system of the nucleus in K562 leukemia cells. The 20S proteasome has been shown to be largely responsible for the degradation of oxidatively modified proteins in the cytoplasm. Nuclear proteins are also subject to oxidation, and the nucleus of mammalian cells contains proteasome. In human beings, tumor cells frequently are subjected to oxidation as a consequence of antitumor chemotherapy, and K562 human myelogenous leukemia cells have a higher nuclear proteasome activity than do nonmalignant cells. Adaptation to oxidative stress appears to be one element in the development of long-term resistance to many chemotherapeutic drugs and the mechanisms of inducible tumor resistance to oxidation are of obvious importance. After hydrogen peroxide treatment of K562 cells, degradation of the model proteasome peptide substrate suc-LLVY-MCA and degradation of oxidized histones in nuclei increases significantly within minutes. Both increased proteolytic susceptibility of the histone substrates (caused by modification by oxidation) and activation of the proteasome enzyme complex occur independently during oxidative stress. This rapid up-regulation of 20S proteasome activity is accompanied by, and depends on, poly-ADP ribosylation of the proteasome, as shown by inhibitor experiments, super(14)C-ADP ribose incorporation assays immunoblotting, in vitro reconstitution experiments, and immunoprecipitation of (activated) proteasome with anti-poly-ADP ribose polymerase antibodies. The poly-ADP ribosylation- mediated activated nuclear 20S proteasome is able to remove oxidatively damaged histones more efficiently and therefore is proposed as an oxidant-stimulatable defense or repair system of the nucleus in K562 leukemia cells. |
Author | Ullrich, Oliver Sitte, Nicolle Grune, Tilman Reinheckel, Thomas Kelvin J. A. Davies Hass, Ralf |
AuthorAffiliation | Clinics of Physical Medicine and Rehabilitation, and † Institute of Anatomy of the Medical Faculty (Charité), Humboldt University, Berlin, Germany; and ‡ Ethel Percy Andrus Gerontology Center, and Division of Molecular Biology, University of Southern California, Los Angeles, CA 90089-0191 |
AuthorAffiliation_xml | – name: Clinics of Physical Medicine and Rehabilitation, and † Institute of Anatomy of the Medical Faculty (Charité), Humboldt University, Berlin, Germany; and ‡ Ethel Percy Andrus Gerontology Center, and Division of Molecular Biology, University of Southern California, Los Angeles, CA 90089-0191 |
Author_xml | – sequence: 1 givenname: Oliver surname: Ullrich fullname: Ullrich, Oliver – sequence: 2 givenname: Thomas surname: Reinheckel fullname: Reinheckel, Thomas – sequence: 3 givenname: Nicolle surname: Sitte fullname: Sitte, Nicolle – sequence: 4 givenname: Ralf surname: Hass fullname: Hass, Ralf – sequence: 5 givenname: Tilman surname: Grune fullname: Grune, Tilman – sequence: 6 fullname: Kelvin J. A. Davies |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/10339569$$D View this record in MEDLINE/PubMed |
BookMark | eNqFks9v0zAUxy00xLrBGYkDijiwUzo_O7ETiUu1MoY0sQrB2XKcl5IqiYvtTOt_j6Ou07bDOPnH-3yfv7a_J-RosAMS8h7oHKjk59tB-3kp5gBzwRh_RWZAS0hFVtIjMqOUybTIWHZMTrzfUErLvKBvyDFQzstclDOiVrbbpYvlKvnZVtZjMq17dDpOFya0tzqgT36MpkPtkpWzAbW3PSbBJktcO11jcnPX1jqi2O2Spe71GuvkqvUhWvVvyetGdx7f3Y-n5Pfl118XV-n1zbfvF4vr1ORZFlIAasBAYwpdF5wigEAoDGcGTakbLmvNKhRUMtk0TJpa58LELVZJURXc8FPyZd93O1Y91gaH4HSntq7ttdspq1v1tDK0f9Ta3iomCsGj_PO93Nm_I_qg-tYb7Do9oB29EqWUAljxXxAkywWTU8dPz8CNHd0Q30AxClxIEBChj49dP9g9_E8EzveAcdZ7h80jRE0JUFMCVCkUgJoSEBX5M4VpQ_wdO1277V7QHaxMhcMpT4CzFwHVjF0X8C5E8sOe3MQMuAc0k0XO-D9OxdgG |
CitedBy_id | crossref_primary_10_1016_j_freeradbiomed_2018_08_037 crossref_primary_10_1016_S1357_2725_02_00386_2 crossref_primary_10_1134_S1990750818030022 crossref_primary_10_1096_fj_00_0540fje crossref_primary_10_1083_jcb_200112074 crossref_primary_10_1074_jbc_M111_277145 crossref_primary_10_1159_000440982 crossref_primary_10_1073_pnas_2111404119 crossref_primary_10_1002_jnr_23517 crossref_primary_10_3389_fmolb_2019_00048 crossref_primary_10_3390_ijms18102036 crossref_primary_10_1515_BC_2008_029 crossref_primary_10_1002_1097_4547_20000815_61_4_436__AID_JNR10_3_0_CO_2_Z crossref_primary_10_1006_abbi_2000_1717 crossref_primary_10_1016_j_freeradbiomed_2021_02_027 crossref_primary_10_1139_o06_083 crossref_primary_10_1111_j_1582_4934_2009_00825_x crossref_primary_10_1016_j_exger_2005_09_004 crossref_primary_10_1586_epr_11_63 crossref_primary_10_1111_j_1749_6632_2000_tb06643_x crossref_primary_10_1021_cr040410w crossref_primary_10_1016_j_bbamem_2003_11_012 crossref_primary_10_1016_S0014_5793_03_00353_3 crossref_primary_10_1016_S1011_1344_01_00211_1 crossref_primary_10_1080_10715760600911154 crossref_primary_10_1111_j_1749_6632_2002_tb04067_x crossref_primary_10_1016_j_freeradbiomed_2009_12_010 crossref_primary_10_1016_j_mam_2016_05_001 crossref_primary_10_1016_j_freeradbiomed_2004_11_030 crossref_primary_10_1016_S0891_5849_00_00317_8 crossref_primary_10_1016_j_redox_2015_07_003 crossref_primary_10_1016_S1047_8477_02_00527_0 crossref_primary_10_1038_nbt_4279 crossref_primary_10_1104_pp_106_092106 crossref_primary_10_1111_j_1398_9995_2011_02551_x crossref_primary_10_1016_S0300_9084_01_01250_0 crossref_primary_10_1002_1873_3468_13778 crossref_primary_10_1002_anie_201305759 crossref_primary_10_1146_annurev_biochem_061516_044908 crossref_primary_10_1096_fj_02_0015com crossref_primary_10_3389_fmicb_2020_02069 crossref_primary_10_1016_j_freeradbiomed_2012_01_022 crossref_primary_10_1515_bmc_2016_0016 crossref_primary_10_1016_j_abb_2012_04_018 crossref_primary_10_1016_j_mrgentox_2004_11_016 crossref_primary_10_1016_S0891_5849_02_00880_8 crossref_primary_10_1515_BC_2002_057 crossref_primary_10_1002_bies_10179 crossref_primary_10_1016_j_ejcb_2005_08_009 crossref_primary_10_1111_j_1742_4658_2006_05318_x crossref_primary_10_1016_j_redox_2013_01_006 crossref_primary_10_1371_journal_pone_0088872 crossref_primary_10_1002_sita_200300021 crossref_primary_10_1016_j_freeradbiomed_2011_08_018 crossref_primary_10_1515_hsz_2017_0158 crossref_primary_10_1186_1477_7827_7_143 crossref_primary_10_1002_bies_1115 crossref_primary_10_1158_0008_5472_CAN_05_0506 crossref_primary_10_1099_jmm_0_022467_0 crossref_primary_10_1016_j_jprot_2013_05_006 crossref_primary_10_1016_j_bcp_2009_12_023 crossref_primary_10_1016_j_biopha_2019_108690 crossref_primary_10_1016_j_pneurobio_2012_01_003 crossref_primary_10_1016_j_phymed_2016_07_007 crossref_primary_10_1016_j_dnarep_2017_08_008 crossref_primary_10_1038_ncb1903 crossref_primary_10_1093_gerona_glx083 crossref_primary_10_1101_gad_183509_111 crossref_primary_10_1016_j_bcp_2004_04_023 crossref_primary_10_1016_j_jgg_2012_09_001 crossref_primary_10_1016_S0531_5565_00_00087_5 crossref_primary_10_1016_j_gde_2006_02_010 crossref_primary_10_1074_jbc_M113_537175 crossref_primary_10_1016_j_jasi_2013_12_005 crossref_primary_10_1016_j_redox_2013_12_029 crossref_primary_10_1515_BC_2006_169 crossref_primary_10_3390_biom4030862 crossref_primary_10_1016_j_freeradbiomed_2011_06_015 crossref_primary_10_18097_PBMC20186402134 crossref_primary_10_3390_biom9050190 crossref_primary_10_1002_jcp_25851 crossref_primary_10_1089_ars_2006_8_163 crossref_primary_10_1371_journal_pone_0032366 crossref_primary_10_1111_j_1471_4159_2004_02802_x crossref_primary_10_1016_S0300_483X_03_00287_7 crossref_primary_10_1016_S0006_291X_03_00809_X crossref_primary_10_1038_nm_4001 crossref_primary_10_1002_embj_201386906 crossref_primary_10_1104_pp_010612 crossref_primary_10_1038_ncb836 crossref_primary_10_1016_j_jprot_2015_11_016 crossref_primary_10_1111_j_1398_9995_2011_02549_x crossref_primary_10_3934_molsci_2015_3_259 crossref_primary_10_1016_j_mam_2016_04_007 crossref_primary_10_1016_S0891_5849_01_00635_9 crossref_primary_10_3389_fncel_2024_1353542 crossref_primary_10_1093_nar_gkx635 crossref_primary_10_1096_fj_03_0177fje crossref_primary_10_1074_jbc_M413007200 crossref_primary_10_1186_1750_9378_2_18 crossref_primary_10_1016_j_exger_2007_03_010 crossref_primary_10_1016_S0531_5565_00_00140_6 crossref_primary_10_1042_BJ20100878 crossref_primary_10_1016_S0006_2952_00_00455_X crossref_primary_10_1007_s10545_012_9511_0 crossref_primary_10_1002_pmic_200800387 crossref_primary_10_1006_abbi_2001_2719 crossref_primary_10_1111_brv_12253 crossref_primary_10_1016_S1357_2725_02_00391_6 crossref_primary_10_1161_CIRCRESAHA_117_311401 crossref_primary_10_1016_j_freeradbiomed_2019_07_020 crossref_primary_10_1016_j_febslet_2007_02_065 crossref_primary_10_1089_ars_2016_6815 crossref_primary_10_1007_s00726_006_0428_5 crossref_primary_10_1016_j_freeradbiomed_2008_12_024 crossref_primary_10_1016_S0891_5849_00_00399_3 crossref_primary_10_3390_medicina56110626 crossref_primary_10_1074_jbc_M209282200 crossref_primary_10_1126_stke_112pt1 crossref_primary_10_1016_j_bbamcr_2013_08_012 crossref_primary_10_1074_jbc_M105170200 crossref_primary_10_1038_s41419_021_03441_0 crossref_primary_10_1016_j_biocel_2004_04_020 crossref_primary_10_1182_blood_V97_9_2830 crossref_primary_10_1152_ajpheart_00189_2012 crossref_primary_10_1016_j_gene_2022_147033 crossref_primary_10_1074_jbc_M206279200 crossref_primary_10_1021_acs_chemrestox_8b00256 crossref_primary_10_1016_j_freeradbiomed_2014_08_012 crossref_primary_10_1038_s12276_024_01385_x crossref_primary_10_1515_hsz_2015_0305 crossref_primary_10_1016_j_freeradbiomed_2010_10_700 crossref_primary_10_1016_S0896_6273_03_00158_2 crossref_primary_10_1111_j_1365_2141_2006_06132_x crossref_primary_10_1371_journal_pone_0101529 crossref_primary_10_1152_physrev_00033_2016 crossref_primary_10_3390_polym12122909 crossref_primary_10_7554_eLife_08467 crossref_primary_10_1007_s12975_017_0567_x crossref_primary_10_1073_pnas_0406182101 crossref_primary_10_1089_ars_2006_8_2007 crossref_primary_10_1007_s10522_004_7379_6 crossref_primary_10_1111_febs_15625 crossref_primary_10_1515_BC_2003_066 crossref_primary_10_1016_j_dnarep_2021_103155 crossref_primary_10_1016_j_yjmcc_2013_10_008 crossref_primary_10_1002_ange_201305759 crossref_primary_10_1016_j_bbapap_2014_08_013 crossref_primary_10_1016_S0891_5849_01_00672_4 crossref_primary_10_1038_cr_2016_86 crossref_primary_10_1096_fj_00_0210com crossref_primary_10_1016_S0891_5849_02_00958_9 crossref_primary_10_1016_S0003_9861_02_00003_6 crossref_primary_10_1002__SICI_1097_0215_20000420_90_2_59__AID_IJC1_3_0_CO_2_4 crossref_primary_10_1002_sita_200400054 crossref_primary_10_4155_fmc_11_175 crossref_primary_10_1016_j_cub_2014_03_033 crossref_primary_10_1007_s00018_012_0938_0 crossref_primary_10_1016_j_abb_2004_03_021 crossref_primary_10_1155_2012_892706 crossref_primary_10_1074_mcp_M110_006924 crossref_primary_10_1006_bbrc_1999_0824 crossref_primary_10_1038_ncb1201_1035 crossref_primary_10_1371_journal_pone_0020073 crossref_primary_10_1002_glia_10137 crossref_primary_10_1007_s11357_020_00295_w crossref_primary_10_1016_j_freeradbiomed_2004_05_025 crossref_primary_10_1111_j_1471_4159_2008_05287_x crossref_primary_10_1006_abbi_2001_2332 crossref_primary_10_1016_j_tins_2006_11_003 crossref_primary_10_1371_journal_pone_0228414 crossref_primary_10_1074_mcp_M110_006122 crossref_primary_10_1016_S0098_2997_03_00014_1 crossref_primary_10_1002__SICI_1097_4644_1999_75_32__149__AID_JCB18_3_0_CO_2 |
Cites_doi | 10.1016/S0021-9258(18)48018-0 10.1126/science.2981433 10.1002/1097-0142(19880415)61:8<1501::AID-CNCR2820610805>3.0.CO;2-4 10.1006/abbi.1996.0303 10.1016/S0021-9258(18)77443-7 10.1146/annurev.bi.65.070196.004101 10.7164/antibiotics.44.113 10.1016/0921-8777(95)00030-5 10.1016/S0021-9258(18)89731-9 10.1016/S0021-9258(17)38913-5 10.1074/jbc.270.5.2344 10.1074/jbc.272.33.20313 10.1074/jbc.270.23.13787 10.1016/S0021-9258(17)35746-0 10.1038/356356a0 10.1093/carcin/13.5.799 10.1016/S0021-9258(18)45983-2 10.1016/0891-5849(90)90155-C 10.1002/j.1460-2075.1995.tb07103.x 10.1074/jbc.271.26.15504 10.1016/S0021-9258(19)37040-1 10.1016/S0021-9258(17)35747-2 10.1073/pnas.94.7.2969 10.1021/bi00211a026 10.1096/fasebj.11.7.9212076 10.1042/bj2590181 10.1016/S0021-9258(18)47564-3 10.1006/abbi.1998.1031 10.1073/pnas.87.18.7071 10.1016/S0021-9258(17)30016-9 |
ContentType | Journal Article |
Copyright | Copyright 1993-1999 The National Academy of Sciences of the United States of America Copyright National Academy of Sciences May 25, 1999 Copyright © 1999, The National Academy of Sciences 1999 |
Copyright_xml | – notice: Copyright 1993-1999 The National Academy of Sciences of the United States of America – notice: Copyright National Academy of Sciences May 25, 1999 – notice: Copyright © 1999, The National Academy of Sciences 1999 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QG 7QL 7QP 7QR 7SN 7SS 7T5 7TK 7TM 7TO 7U9 8FD C1K FR3 H94 M7N P64 RC3 7X8 5PM |
DOI | 10.1073/pnas.96.11.6223 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Nucleic Acids Abstracts Ecology Abstracts Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management Entomology Abstracts Genetics Abstracts Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Chemoreception Abstracts Immunology Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | Virology and AIDS Abstracts MEDLINE CrossRef MEDLINE - Academic Nucleic Acids Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) |
EISSN | 1091-6490 |
EndPage | 6228 |
ExternalDocumentID | PMC26863 43626929 10339569 10_1073_pnas_96_11_6223 96_11_6223 47852 |
Genre | Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S Journal Article Feature |
GrantInformation_xml | – fundername: NIEHS NIH HHS grantid: R56 ES003598 – fundername: NIEHS NIH HHS grantid: ES 03598 – fundername: NIEHS NIH HHS grantid: R01 ES003598 |
GroupedDBID | --- -DZ -~X .55 .GJ 0R~ 123 29P 2AX 2FS 2WC 3O- 4.4 53G 5RE 5VS 85S AACGO AAFWJ AANCE AAYJJ ABBHK ABOCM ABPLY ABPPZ ABTLG ABXSQ ABZEH ACGOD ACHIC ACIWK ACNCT ACPRK ADQXQ ADULT ADXHL AENEX AEUPB AEXZC AFFNX AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS AQVQM AS~ BKOMP CS3 D0L DCCCD DIK DU5 E3Z EBS EJD F5P FRP GX1 H13 HGD HH5 HQ3 HTVGU HYE IPSME JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JST KQ8 L7B LU7 MVM N9A NEJ NHB N~3 O9- OK1 P-O PNE PQQKQ R.V RHI RNA RNS RPM RXW SA0 SJN TAE TN5 UKR VOH W8F WH7 WHG WOQ WOW X7M XSW Y6R YBH YKV YSK ZCA ZCG ~02 ~KM - 02 08R 0R 1AW 55 AAPBV ABFLS ABPTK ADACO ADZLD AFDAS AJYGW AS ASUFR DNJUQ DOOOF DWIUU DZ F20 GJ JSODD KM OHM PQEST RHF VQA X XFK XHC ZA5 AAYXX CITATION CGR CUY CVF ECM EIF NPM VXZ YIF YIN 7QG 7QL 7QP 7QR 7SN 7SS 7T5 7TK 7TM 7TO 7U9 8FD C1K FR3 H94 M7N P64 RC3 7X8 5PM |
ID | FETCH-LOGICAL-c544t-110c1c1fc8ad830e116e18c32cec9af37da2be60727ff27cda56ca2b2b76b83c3 |
ISSN | 0027-8424 |
IngestDate | Thu Aug 21 18:16:27 EDT 2025 Fri Jul 11 03:06:26 EDT 2025 Fri Jul 11 09:33:15 EDT 2025 Mon Jun 30 08:39:21 EDT 2025 Wed Feb 19 02:35:25 EST 2025 Tue Jul 01 00:46:32 EDT 2025 Thu Apr 24 23:00:10 EDT 2025 Wed Nov 11 00:29:56 EST 2020 Thu May 30 08:52:11 EDT 2019 Thu May 29 08:40:52 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c544t-110c1c1fc8ad830e116e18c32cec9af37da2be60727ff27cda56ca2b2b76b83c3 |
Notes | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-2 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 To whom reprint requests should be addressed at: Ethel Percy Andrus Gerontology Center, University of Southern California, 3715 McClintock Avenue, Room 306, Los Angeles, CA 90089-0191. e-mail: kelvin@usc.edu. Communicated by E. R. Stadtman, National Institutes of Health, Bethesda, MD |
PMID | 10339569 |
PQID | 201367161 |
PQPubID | 42026 |
PageCount | 6 |
ParticipantIDs | pnas_primary_96_11_6223 crossref_primary_10_1073_pnas_96_11_6223 proquest_journals_201367161 crossref_citationtrail_10_1073_pnas_96_11_6223 proquest_miscellaneous_17256273 pnas_primary_96_11_6223_fulltext pubmedcentral_primary_oai_pubmedcentral_nih_gov_26863 proquest_miscellaneous_69776128 pubmed_primary_10339569 jstor_primary_47852 |
ProviderPackageCode | RNA PNE CITATION AAYXX |
PublicationCentury | 1900 |
PublicationDate | 19990525 1999-05-25 1999-May-25 |
PublicationDateYYYYMMDD | 1999-05-25 |
PublicationDate_xml | – month: 5 year: 1999 text: 19990525 day: 25 |
PublicationDecade | 1990 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Washington |
PublicationTitle | Proceedings of the National Academy of Sciences - PNAS |
PublicationTitleAlternate | Proc Natl Acad Sci U S A |
PublicationYear | 1999 |
Publisher | National Academy of Sciences of the United States of America National Acad Sciences National Academy of Sciences The National Academy of Sciences |
Publisher_xml | – name: National Academy of Sciences of the United States of America – name: National Acad Sciences – name: National Academy of Sciences – name: The National Academy of Sciences |
References | e_1_3_3_17_2 e_1_3_3_16_2 e_1_3_3_19_2 e_1_3_3_18_2 e_1_3_3_13_2 e_1_3_3_12_2 e_1_3_3_15_2 e_1_3_3_14_2 e_1_3_3_11_2 e_1_3_3_30_2 e_1_3_3_10_2 e_1_3_3_31_2 e_1_3_3_6_2 e_1_3_3_5_2 e_1_3_3_8_2 e_1_3_3_7_2 e_1_3_3_28_2 e_1_3_3_9_2 e_1_3_3_27_2 e_1_3_3_29_2 e_1_3_3_24_2 e_1_3_3_23_2 e_1_3_3_26_2 e_1_3_3_25_2 e_1_3_3_2_2 e_1_3_3_20_2 e_1_3_3_1_2 e_1_3_3_4_2 e_1_3_3_22_2 e_1_3_3_3_2 e_1_3_3_21_2 |
References_xml | – ident: e_1_3_3_11_2 doi: 10.1016/S0021-9258(18)48018-0 – ident: e_1_3_3_26_2 doi: 10.1126/science.2981433 – ident: e_1_3_3_28_2 doi: 10.1002/1097-0142(19880415)61:8<1501::AID-CNCR2820610805>3.0.CO;2-4 – ident: e_1_3_3_15_2 doi: 10.1006/abbi.1996.0303 – ident: e_1_3_3_23_2 doi: 10.1016/S0021-9258(18)77443-7 – ident: e_1_3_3_18_2 doi: 10.1146/annurev.bi.65.070196.004101 – ident: e_1_3_3_24_2 doi: 10.7164/antibiotics.44.113 – ident: e_1_3_3_29_2 doi: 10.1016/0921-8777(95)00030-5 – ident: e_1_3_3_9_2 doi: 10.1016/S0021-9258(18)89731-9 – ident: e_1_3_3_10_2 doi: 10.1016/S0021-9258(17)38913-5 – ident: e_1_3_3_12_2 doi: 10.1074/jbc.270.5.2344 – ident: e_1_3_3_16_2 doi: 10.1074/jbc.272.33.20313 – ident: e_1_3_3_20_2 doi: 10.1074/jbc.270.23.13787 – ident: e_1_3_3_2_2 doi: 10.1016/S0021-9258(17)35746-0 – ident: e_1_3_3_31_2 doi: 10.1038/356356a0 – ident: e_1_3_3_6_2 doi: 10.1093/carcin/13.5.799 – ident: e_1_3_3_27_2 doi: 10.1016/S0021-9258(18)45983-2 – ident: e_1_3_3_7_2 doi: 10.1016/0891-5849(90)90155-C – ident: e_1_3_3_30_2 doi: 10.1002/j.1460-2075.1995.tb07103.x – ident: e_1_3_3_13_2 doi: 10.1074/jbc.271.26.15504 – ident: e_1_3_3_8_2 doi: 10.1016/S0021-9258(19)37040-1 – ident: e_1_3_3_3_2 doi: 10.1016/S0021-9258(17)35747-2 – ident: e_1_3_3_17_2 doi: 10.1073/pnas.94.7.2969 – ident: e_1_3_3_5_2 doi: 10.1021/bi00211a026 – ident: e_1_3_3_1_2 doi: 10.1016/0891-5849(90)90155-C – ident: e_1_3_3_14_2 doi: 10.1096/fasebj.11.7.9212076 – ident: e_1_3_3_4_2 doi: 10.1042/bj2590181 – ident: e_1_3_3_21_2 doi: 10.1016/S0021-9258(18)47564-3 – ident: e_1_3_3_25_2 doi: 10.1006/abbi.1998.1031 – ident: e_1_3_3_19_2 doi: 10.1073/pnas.87.18.7071 – ident: e_1_3_3_22_2 doi: 10.1016/S0021-9258(17)30016-9 |
SSID | ssj0009580 |
Score | 2.078107 |
Snippet | The 20S proteasome has been shown to be largely responsible for the degradation of oxidatively modified proteins in the cytoplasm. Nuclear proteins are also... |
SourceID | pubmedcentral proquest pubmed crossref pnas jstor |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 6223 |
SubjectTerms | Adenosine diphosphate Adenosine Diphosphate Ribose - metabolism Adenosine Triphosphatases - metabolism Antibodies Biological Sciences Carbon Radioisotopes Cell nucleus Cell Nucleus - metabolism Cells Cellular biology Chemotherapy Coumarins - metabolism Cysteine Endopeptidases - metabolism DNA damage Enzyme Activation Fluorescent Dyes Gels Histones Histones - drug effects Histones - metabolism Humans Hydrogen Hydrogen Peroxide - pharmacology K562 Cells Leukemia Multienzyme Complexes - metabolism Oligopeptides - metabolism Oxidation Oxidation-Reduction Peroxides Poly(ADP-ribose) Polymerases - metabolism Proteasome Endopeptidase Complex Proteins Substrate Specificity Tumors |
Title | Poly-ADP Ribose Polymerase Activates Nuclear Proteasome to Degrade Oxidatively Damaged Histones |
URI | https://www.jstor.org/stable/47852 http://www.pnas.org/content/96/11/6223.abstract https://www.ncbi.nlm.nih.gov/pubmed/10339569 https://www.proquest.com/docview/201367161 https://www.proquest.com/docview/17256273 https://www.proquest.com/docview/69776128 https://pubmed.ncbi.nlm.nih.gov/PMC26863 |
Volume | 96 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF5MeumlNOnLTR976CHFyLW12tXqaJqWUKhjQgy5CWm0IgZFLpEMTX9Zf15nH3rY2ND2ImxpJaSdT_NYzXxDyIcgjECrPY9DBl7AmS5WTrnHRRYFMoAUhC5O_j4XF8vg2w2_GQx-97KWNnU6hl9760r-R6q4D-Wqq2T_QbLtRXEH_kb54hYljNu_kvFiXTx4s_PF6GqV6rxz_V8vMmmyETB9yxSqMc1YnNzrkgAUaLW-M80yzjVJRKZGlz9XmeH-Lh4QAXeoXTJLHVK65ELnuC5aQ1c1aQXzZh1x1lWlOFVRjbzRYt71OF4WBepbs4JzWehMkPY7j1qVtwo1SbGTraQXfVa17d1n0dohMLGN3q-SIu8WLSzRAfdsgXOf83v_DbqH2PK5jVtuP2H1tbmPFjawNdiNNrf9cRvUTnu6Wfi2stnZefwr99oQVHq68XGZVONIoEkZdyduEXMHoeRo_B_5GKD4xiT06Z6lLX5yd9iQSoXs086Ft_whmxKreXZx0L6YZzd1t-cLXT8lT1wQQ2cWkcdkoMoTctxMLT1zXOYfn5G4gSi1EKUdRGkLUeogSjuI0npNHURpD6LUQZQ2EH1Oll-_XH--8FxPDw94ENQeepswhWkOMskkm6jpVKipBOaDgijJWZglfqrEBN3qPPdDyBIuAHf5aShSyYC9IEclXv8VoTkIkSupa68hUBOeKJAyhUmucjYBFg3JuJnZGBzhve67UsQm8SJksZ7lOBIYBcdaFENy1p7ww3K9HB56YkTVjjNgGJKXZlyzsz-eHjgS5y7Ja0hOG3HHTsdUsW8oFTEqG5L37VE0APqrXlKq9aaKMQLBGCZkh0cIjPEwkJH69gx4ek_HWMQFThXfglU7QJPPbx8pV7eGhN4XUrDXe6fhlDzu3vk35Ki-36i36LrX6TvzlvwBomL1cg |
linkProvider | ABC ChemistRy |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Poly-ADP+Ribose+Polymerase+Activates+Nuclear+Proteasome+to+Degrade+Oxidatively+Damaged+Histones&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+-+PNAS&rft.au=Ullrich%2C+Oliver&rft.au=Reinheckel%2C+Thomas&rft.au=Sitte%2C+Nicolle&rft.au=Hass%2C+Ralf&rft.date=1999-05-25&rft.pub=National+Academy+of+Sciences+of+the+United+States+of+America&rft.issn=0027-8424&rft.volume=96&rft.issue=11&rft.spage=6223&rft.epage=6228&rft_id=info:doi/10.1073%2Fpnas.96.11.6223&rft.externalDocID=47852 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F96%2F11.cover.gif |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F96%2F11.cover.gif |